Scordo MG - Search Results

1

Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy.

Spina E, Arena D, Scordo MG, Fazio A, Pisani F, Perucca E. Spina E, et al. Among authors: scordo mg. Ther Drug Monit. 1997 Oct;19(5):535-8. doi: 10.1097/00007691-199710000-00009. Ther Drug Monit. 1997. PMID: 9357097

2

Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.

Spina E, Avenoso A, Campo GM, Scordo MG, Caputi AP, Perucca E. Spina E, et al. Among authors: scordo mg. Br J Clin Pharmacol. 1997 Mar;43(3):315-8. doi: 10.1046/j.1365-2125.1997.00539.x. Br J Clin Pharmacol. 1997. PMID: 9088587 Free PMC article. Clinical Trial.

3

Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.

Facciolà G, Avenoso A, Scordo MG, Madia AG, Ventimiglia A, Perucca E, Spina E. Facciolà G, et al. Among authors: scordo mg. Ther Drug Monit. 1999 Jun;21(3):341-5. doi: 10.1097/00007691-199906000-00017. Ther Drug Monit. 1999. PMID: 10365650 Clinical Trial.

4

Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.

Spina E, Avenoso A, Facciolà G, Salemi M, Scordo MG, Giacobello T, Madia AG, Perucca E. Spina E, et al. Among authors: scordo mg. Ther Drug Monit. 2000 Aug;22(4):481-5. doi: 10.1097/00007691-200008000-00019. Ther Drug Monit. 2000. PMID: 10942191

5

Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine.

Spina E, Avenoso A, Facciolà G, Scordo MG, Ancione M, Madia A. Spina E, et al. Among authors: scordo mg. Ther Drug Monit. 2001 Jun;23(3):223-7. doi: 10.1097/00007691-200106000-00007. Ther Drug Monit. 2001. PMID: 11360029

6

No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites.

Spina E, Avenoso A, Scordo MG, Ancione M, Madia A, Levita A. Spina E, et al. Among authors: scordo mg. Ther Drug Monit. 2001 Dec;23(6):675-8. doi: 10.1097/00007691-200112000-00014. Ther Drug Monit. 2001. PMID: 11802103

7

Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.

Scordo MG, Spina E, Dahl ML, Gatti G, Perucca E. Scordo MG, et al. Basic Clin Pharmacol Toxicol. 2005 Nov;97(5):296-301. doi: 10.1111/j.1742-7843.2005.pto_194.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16236141 Free article.

8

Cytochrome P450 polymorphisms and response to antipsychotic therapy.

Scordo MG, Spina E. Scordo MG, et al. Pharmacogenomics. 2002 Mar;3(2):201-18. doi: 10.1517/14622416.3.2.201. Pharmacogenomics. 2002. PMID: 11972442 Review.

9

Clinically significant drug interactions with antidepressants in the elderly.

Spina E, Scordo MG. Spina E, et al. Among authors: scordo mg. Drugs Aging. 2002;19(4):299-320. doi: 10.2165/00002512-200219040-00004. Drugs Aging. 2002. PMID: 12038880 Review.

10

Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction.

Spina E, Avenoso A, Scordo MG, Ancione M, Madia A, Gatti G, Perucca E. Spina E, et al. Among authors: scordo mg. J Clin Psychopharmacol. 2002 Aug;22(4):419-23. doi: 10.1097/00004714-200208000-00014. J Clin Psychopharmacol. 2002. PMID: 12172343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters